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ABSTRACT
Enterococci are members of commensal flora of animals and insects, but are also important opportunistic
pathogens. Our objective was to observe if there was any difference of virulence in several groups of E.
faecalis, mainly between vancomycin-resistant E. faecalis (VREFS) of colonization and infection. VREFS and
vancomycin-sensitive E. faecalis from Brazil were screened for the presence of virulence factor genes.
Phenotypic assays were used to assess in vitro expression, to understand the pathogenic potential of these
isolates and to determine whether a correlation exists between virulence and antibiotic resistance. Different
virulence profiles were found suggesting that the disseminating clone may have generated several variations.
However, our study showed that one constellation of traits appeared most commonly: gelatinase, aggregation
substance and esp (GEA). These factors are important because they have been implicated in cell aggregation
and biofilm formation. Biofilm formation may promote the conjugation of plasmids harboring resistance and
virulence genes, enhancing the probability of entry of new resistance genes into species. Curiously, the
profile GEA was not exclusive to VREFS, it was the second most observed in VSEFS isolates from colonization
and infection in hospitalized patients and also from rectal swabs of healthy volunteers. Such strains appear
to represent the entry gateway to new resistance genes into E. faecalis and may contribute to the spreading
of E. faecalis mainly in hospitals.
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INTRODUCTION
Enterococci are members of the commensal flora of human,
animals and insects, but are also important opportunistic
pathogens that often posses several vitulence factors and
resistance to multiple antibiotics including vancomycin (4). Of
the five phenotypes of glycopeptide resistance described
(4,11,26) VanA and VanB are the most commom (26).
Cytolysin (Cyl), enterococcal surface protein (Esp),
gelatinase (GelE) and aggregation substance (Agg) are among
the virulence factors able to influence host/parasite
relationships that were described in Enterococcus faecalis
(7,15,21). Cytolysin is a hemolytic toxin that also has bacteriocin
activity (7). Esp is a surface protein that enhances the biofilm
formation by E. faecalis (23). Gelatinase is a metalloprotease
that cleaves several substrates including insoluble collagen
fragments, as well as the pheromone and inhibitor peptides
involved in conjugative plasmid transfer of E. faecalis (25).  A
role for GelE in biofilm development has also been recently
described (14,15). Aggregation substance, encoded by asc 10,
asa1 and other related genes, is a pheromone-inducible surface
protein that promotes aggregation during bacterial conjugation
in E. faecalis (5). Some of these factors, including cytolysin,
Agg and Esp were found to be encoded on a large, 153-kb
pathogenicity island (20). These virulence factors may play a
role in promoting persistence of enterococci in the nosocomial
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environment, and consequently inter and intra-hospitals
dissemination.
In Brazil, vancomycin resistant Enterococci (VRE) have been
isolated only from hospitalized patients (27) and have not yet
been described in animals despite the past use of avoparcin as
growth promoter (16). The first VRE strain in Brazil was isolated
in 1996 and was E. faecium classified as VanD-4 and ST281 by
MLST (1,10,11).  However, no other VanD strains have been
reported in Brazil. On the other hand, a predominant clone of
vancomycin-resistant E. faecalis (VREFS) VanA has recently been
disseminating throughout hospitals in Sao Paulo and other cities
(8,18,19). It was of interest to identify virulence factors and
antibiotic resistance profiles among isolates of the disseminating
clone and compare them with subsets of vancomycin-sensitive
E. faecalis (VSEFS) from several sources in Brazil.  In addition, to
know the isolate  pathogenicities was the base for understanding
if a correlation exists between virulence factors and resistance
and to determine whether the dissemination of this E. faecalis
clone represents an important shift in the spread of vancomycin
resistance to more virulent lineages.
MATERIAL AND METHODS
A total of 115 isolates of E. faecalis from several regions of
Brazil, were divided into two major groups, VREFS (24 isolates)
and VSEFS (91 isolates). VREFS isolates were recovered only
from hospitalized patients in Brazil, and were subdivided in 2
subsets: 8 VREFS from colonized hospitalized patients (chp)
and 16 VREFS from infections in hospitalized patients (ihp).
The 91 VSEFS were subdivided into 3 different subsets: 41
VSEFS ihp, 34 VSEFS chp and 16 VSEFS from colonized
volunteers within the community (cvc). Species and genotype
identification of VRE were performed by PCR as previously
described (13). Tests for high-level gentamicin (500 μg/mL) and
streptomycin (2,000mg/mL) and Minimal Inhibitory
Concentrations (MICs) of vancomycin and penicillin were
determined by the agar dilution method as recommended by
CLSI (6).
Total DNA was prepared as described (21), and 200 ng of
each DNA sample was bound to a zeta-probe nylon membrane
(Bio Rad, Hercules, California) using a 96 wells microfiltration
apparatus (Bio Rad, Bio-Dot®). The DNA was crosslinked to
the membrane using an ultraviolet multilinker (UVC 515, Ultra-
Lum, Carson, California, USA), and hybridized to radioactive
probes. Genes of interest were amplified by PCR using the
primers described in Table 1. The probes were labeled using the
RadPrime DNA Labeling System (Invitrogen, California, USA).
Gelatinase production was determined on Todd-Hewitt agar
supplemented with 3% gelatin (22). Cytolysin production was
determined by observing β-hemolysis on BHI agar supplemented
with 5% (v/v) human erythrocytes. Control strains included: E.
faecalis JH2SS (pAD1) for the asa1 gene; E. faecalis MMH594
for the genes asc10, cylLL, cylLS, cylA and esp; E. faecalis OG1RF
for the gelE gene.
Agg expression was detected by the clumping assay (12)
with pheromones obtained from E. faecalis FA2-2. To precipitate
pheromones, an overnight 1:10 culture of plasmid-free E.
faecalis FA2-2 was subcultured into 200 mL of THB for 6 h at
37ºC. The cells were removed by centrifugation, and the
supernatant was filtered through a 0.2 μm filter (Nalgen®, Nalge
Table 1. Primers used to make the specific probes for hybridization.
Gene Primer name Sequence 5’-3’ Lenght of the fragment Reference
cylLL cylLL F AAC TAA GTG TTG AGG AAA TG 159bp (2)
cylLL R AAA GAC ACA ACT ACA GTT AC
cylLs cylLs F AGA ACTTGT TGG TCC TTC 134 bp (2)
cylLs R GCT GAA AAT AAT GCA CCT AC
cylA cylA F ACA GGT TAT GCA TCA GAT CT 507bp (2)
cylA R AAT TCA CTC TTG GAG CAA TC
esp** Esp14F AGA TTT CAT CTT TGA TTC TTG G 500 bp AF034779*
Esp12R AAT TGA TTC TTT AGC ATC TGG
gelE gelE F AATTGCTTTACACGGAACGG 548bp (2)
gelE R GAGCCATGGTTTCTGGTTGT
Agg 1*** Agg 1 F AGT GAC GAT TGA TTTATC CAA AGT G 446bp X17214 and
(asa1 and asc10 ) M64978*
Agg 1 R CGT TCG GAA GAT TTC ACT TCA TAA T
* The primers were designed based on the sequences registered in the GenBank. ** The sequences of esp primers were provided by Dr. Nathan
Shankar, College of Pharmacy, Oklahoma University Health Sciences Center, OK, USA. *** Primers are the same for amplify both genes, but
the templates were different.
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Nunc International, Rochester, NY). Pheromones were
precipitated from supernatant with trichloroacetic acid at a final
concentration of 5% for 18h at 4ºC. Precipitate was collected
by centrifugation at 8410 g for 15 minutes, dried and dissolved
in 10 mL of Todd Hewitt Broth (THB), and again filtered.
All VRE isolates were typed by pulsed-field gel
electrophoresis (PFGE) as described (3). Restriction fragments
were separated using Gene Navigator apparatus (Amersham
Biosciences) at 180 V for 25 h, at 7ºC, adjusted for  pulse times
of 20 s for 10 h, 8 s for 10 h and 3 s for 5 h. PFGE clonal groups
were assigned according to the criteria of Tenover et al. (24).
The project protocol was approved by the Research Ethical
Committee of the Faculty of Pharmaceutical Sciences of
Ribeirão Preto, under the number 28/CEP/FCFRP.
Statistical analysis was performed by Fisher’s exact test using
GraphPad Prism software (San Diego, California, USA).
RESULTS AND DISCUSSION
PFGE typing of all VREFS in this study confirmed the
presence of the VREFS type A strain in several hospitals in
different cities of Brazil (Table 2 and Fig.1). All but one VREFS
were resistant to penicillin and high levels of gentamicin, but
susceptible to streptomycin. The remaining PFGE types,
resistance and virulence profiles are shown in Table 2.
Virulence factor profiles were established by determining
the presence of the gene and confirming its expression in the
phenotypic assays, except for esp. This study has shown that
PFGE type A strain appears to have undergone small variations
with time, since several virulence profiles were found in different
isolates of the same strain. Among the varied virulence profiles,
one was the most common among isolates of this disseminating
clone. Twelve out 16 type A isolates possessed the GelE, Agg
and esp profile (Table 2). Our results suggest that loss of some
factors resulted in the variations found in the 4 remaining type
A isolates.
Among the VREFS, cytolysin was presented in only one
isolate that also produced gelatinase. This isolate was a subtype
A1 strain, closely related to the disseminating clone in Brazil.
However, another VREFS subtype A1, isolated 2 years later,
possessed the GelE, Agg and esp profile. The data suggests
that either the first isolate acquired the cytolysin operon,
Figure 1. Agarose gel electrophoresis of genomic DNA. a) Results of pulsed-field Gel electrophoresis analysis of VREFS isolated
in Brazil. 1- M, Lambda PFMarker (New England BioLabs), 2- VREFS ihp 13, 3- VREFS chp 5, 4- VREFS chp 18, 5- VREFS chp 22, 6-
VREFS ihp 8, 7- VREFS chp 17, 8- VREFS ihp 7, 9- VREFS ihp 9, 10- VREFS chp 4, 11- VREFS ihp 25, 12- VREFS ihp 1, 13- M Lambda
PFMarker (New England BioLabs); b) Dendrogram of PFGE of the strains calculated with percent similarity performed by MVSP 3.0
software. chp,  isolates of hospitalized and colonized patients; ihp, isolates from infection in hospitalized patients.
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perhaps on a conjugative plasmid, but lost esp, or had not
acquired it yet. In addition, both Agg genes were detected in
the strain, but not their expression. In our study, the total
incidence of cytolysin among VSEFS isolates was 12% (11 out
of 91), in concordance with reported observations (9).
The presence of the gelatinase gene by itself, for instance,
does not ensure its expression. The expression of virulence
factor’s gene may be controlled by a very complex regulation
network and is not the focus of this study. On the other hand,
some VSEFS isolates were positive for clumping but lacked the
two aggregation substance genes studied, indicating that other
Agg genes may be involved in the aggregation by some VSEFS.
This was especially true in the VSEFS cvc group, among which
31.2% were positive by phenotypic assay, but negative for asc10
and asa1. Strains with asa1 and asc10 genes, but negative in
phenotypic assays, were also found suggesting that the presence
of these genes may not predict their expression. In summary,
asa1 and asc10 are present and expressed in a large number of
VREFS isolates, but greater variability exists in VSEFS isolates.
Subtypes A2, A3 and A4 were isolated in different periods
of time, but presented the same GelE, Agg and esp virulence
profile. The only VREFS type C strain in this study showed the
Table 2.  Date, susceptibility profile, virulence factors and PFGE profile present in vancomycin-resistant E. faecalis isolates from
Brazil.
Samples Isolation Virulence factors Susceptibility profile PFGE profile
Date Source a Genes b / Expression profilec P /HLAR G /HLAR S d
VREFS chpe
4 1998 CSSM-SP gelE, asa1, asc10 esp / GAE R/R/S A2
5 1998 CSSM-SP gelE, asa1, asc10 esp / GAE R/R/S A
6 1998 CSSM-SP asa1, asc10 esp / AE R/R/S A
18 1999 HCSP-SP gelE, asa1, asc10 esp / GAE R/R/S A
22 2000 HCASP-SP gelE, asa1, asc10 esp / GAE R/R/S A
24 1998 CSSM-SP gelE, asa1, asc10 esp / AE R/R/S C
17 1999 CSSM-SP gelE, asa1, asc10 esp / GAE R/R/S A
23 1999 HSPSP-SP gelE, asa1, asc10 esp / GAE R/S/S A
VREFS ihpf
1 1998 CSSM-SP gelE, asa1, asc10 / N R/R/S B
2 1998 CSSM-SP gelE, asa1, asc10 esp / GAE R/R/S A
3 1998 CSSM-SP gelE,cylLLLSA, asa1, asc10 / GC R/R/S A1
7 2000 HEDPA - RS gelE, asa1, asc10 esp / GAE R/R/S A1
8 2000 HPUCP-RS gelE, asa1, asc10 esp / GAE R/R/S A
9 2000 HCC-PR gelE, asa1, asc10 esp / GAE R/R/S A2
10 2000 HCC-PR gelE, asa1, asc10 esp / GAE R/R/S A3
11 1999 CSSM-SP gelE, asa1, asc10 esp / GAE R/R/S A
12 1999 CSSM-SP gelE, asa1, asc10 esp / GAE R/R/S A
13 1999 CSSM-SP gelE, asa1, asc10 esp / GAE R/R/S A
14 1999 CSSM-SP gelE, asa1, asc10 / GA R/R/S A
15 1999 CSSM-SP gelE, asa1, esp / GAE R/R/S A
16 1999 CSSM-SP gelE, asa1, asc10 esp / GAE R/R/S A
20 2000 CSSM-SP gelE, asa1, asc10 esp / GE R/R/S A
21 1999 HSPSP-SP gelE, asa1, asc10 esp / G R/R/S A
25 2003 UFU - MG gelE, asa1, asc10 esp / GAE R/R/S A4
a CSSM-SP – Casa de Saúde Santa Marcelina – SP, HCSP-SP- Hospital do Coração de São Paulo, HSPSP-SP – Hospital do Servidor Público de
São Paulo, HED PA – RS– Hospital Ernesto Dornelles - Porto Alegre - RS, HPUCPA – RS- Hospital da Pontifícia Universidade Católica de Porto
Alegre - RS, HCC-PR – Hospital das Clínicas de Curitiba - PR, HCASP-SP – Hospital Cruz Azul – SP, UFU – MG, Universidade Federal de
Uberlandia. b gelE, gelatinase gene; cylLLLSA, cytolysin genes; asa1 and asc10 are aggregation substance’s genes; esp, enterococcal surfae protein
gene. c G, gelatinase, A, aggregation, E, esp presence, C, cytolysin activity, N, none of the virulence factors studied found were expressed. d P,
penicillin, HLAR G, high level aminoglycoside resistance - gentamycin, HLAR S, high level Aminoglycoside resistance - streptomycin, R,
resistant and S, susceptible. e chp, isolates of hospitalized colonization patients. f ihp, isolates of infection in hospitalized patients.
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Agg-esp profile and had a non-expressed gelE gene. Finally,
there was only one VREFS type B in this study that in spite of
having gelE and Agg genes did not express them. Therefore, it
did not fit any of the virulence factor profiles.  Only one of the
VSEFS strains (chp group) did not possess any of the virulence
factor genes tested but another VSEFS (ihp group) possessed
all. There was no absolute correlation between the presence of
particular virulence factors and resistance to the antibiotics in
the VSEFS isolates (data not shown).  Factors GelE, Agg, Cyl
and esp were detected in isolate VSEFS iph JF7 which was
sensitive to all antibiotics.  Resistance to penicillin was observed
in all VREFS, most were also resistant to high level gentamicin
but all were sensitive to high level streptomycin (Table 2)
Marques et al. (17) described that there was no significant
association between virulence factor markers and clinical
sources in a different set of strains isolated in Brazil. The most
frequent genotypic profile detected by Marques et al. (17)
was efa (adhesin), esp and gelE.  We did not search for efa in
our work, but in both VREFS and VSEFS groups, most isolates
exhibited the following profiles: Agg and esp, or GelE, Agg
and esp.  All VSEFS subsets showed profiles as, esp only,
gelatinase only, and Cyl, Agg and esp. Profiles GelE and Cyl,
and GelE and Agg were detected among VSEFS from colonized
volunteers of the community, and from infections in hospitalized
patient. Agg occurring by itself was found only in VSEFS
from colonization subsets.
In conclusion, there was no difference statistically significant
in the frequency of the virulence factor’s genes found in the
type A strains (Table 2) when compared both groups of VREFS
(chp and ihp) (Fisher’s exact test, p = 0.59). The virulence factors
GelE, Agg and esp occur together in most VREFS type A
isolates, the disseminating clone occurring in Brazil. However,
this constellation of traits is not exclusive of VREFS but it was
also observed in VSEFS isolates of colonization and infection
patients as well as of healthy colonization volunteers. These
factors have all been shown by other investigators to aggregate
cells, to contribute to biofilm formation and to be particularly
important in the dissemination or acquisition of resistances by
promoting cell-cell contact and the conjugal transfer of plasmids
harboring resistance and virulence genes. Such strains appear
to represent the entry gateway to new resistance genes into E.
faecalis and may contribute to the spreading of E. faecalis
mainly in the hospitals.
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RESUMO
Fatores de virulência em Enterococcus faecalis
resistentes e suscetível à vancomicina isolados no
Brasil
Enterococci são membros da microbiota comensal de animais
e insetos, mas também são importantes patógenos oportunistas.
Nosso objetivo foi observar se há qualquer diferença na
virulência nos diversos grupos de Enterococcus faecalis,
principalmente nos E. faecalis resistente à vancomicina (VREFS)
isolados de colonização e infecção. VREFS e E. faecalis
sensíveis à vancomicina (VSEFS) do Brasil foram pesquisadas
quanto a presença de fatores de virulência. Ensaios fenotípicos
foram usados para obter a expressão in vivo, entender o potencial
patogênico destas amostras e determinar se existe correlação
entre virulência e resistência a antibióticos. Diferentes perfis de
virulência foram encontrados sugerindo que o clone que está
se disseminado pode ter gerado diversas variações. No entanto,
nosso estudo mostrou que um conjunto de fatores parece ser
mais comum entre as amostras: gelatinase, substância de
agregação e esp (GEA). Estes fatores tem sido correlacionados
com a agregação de células e formação de biofilmes. A formação
de biofilme pode promover a conjugação de plasmídeos
contendo genes de resistência entre as espécies. Curiosamente,
o perfil GAE não foi exclusivo para VREFS, foi o segundo mais
observado em amostras VSEFS provenientes de colonização e
infecção em pacientes hospitalizados e também de swabs retais
de voluntários saudáveis. Tais linhagens pacerem representar
a “porta de entrada” para novos genes de resistência em E.
faecalis e podem contribuir para a disseminação de E. faecalis
principalmente nos hospitais.
Palavras-chave: Enterococcus faecalis, VRE, Esp, gelatinase,
substância de agregação
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